Filing Flows › BioStem Technologies (BSEM) › Stock forecast & fair value
BioStem Technologies (BSEM) stock forecast and price target
BioStem Technologies (BSEM) trades at $1.13. One analyst's price target is $7.00 (+519%).
BioStem Technologies' latest quarter
BioStem Technologies, Q2 2026: revenue $7.9M (-28% year over year), operating margin -106.3%, net loss $9.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for BSEM stock?
One analyst's 12-month target is $7.00, +519% from $1.13. The average rating is none.
Does BioStem Technologies usually beat earnings estimates?
It beat the consensus EPS estimate in 0% of the quarters on record.
Is BSEM stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.